Treatment is based on the<unk><unk>  of the individual. <unk><unk>  is performed to determine which individuals with WPW syndrome are at<unk>  for sudden cardiac death (SCD). Sudden cardiac death in these individuals is due to the propagation of an atrial arrhythmia to the ventricles at a very high rate. Noninvasive tests have a 70% positive predictive value and 30% negative predictive value for identifying pathways with life-threatening properties.Electrophysiologic studies are useful for evaluation of patients' symptoms.
Wolff-Parkinson-White syndrome risk stratification
Wolff-Parkinson-White syndrome diagnosis
Wolff-Parkinson-White syndrome classification scheme
Asperger syndrome classification
Brugada syndrome classification
Brugada syndrome diagnostic criteria
Parkinson's disease differential diagnosis
Wolff-Parkinson-White syndrome epidemiology and demographics